Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Nascent Biotech Inc. (NBIO) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Nascent Biotech Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1622057.
Total stock buying since 2015: $3,308,333.
Total stock sales since 2015: $1,300.
Total stock option exercises since 2015: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2023 | 190,000 | $13,600 | 0 | $0 | 0 | $0 |
| 2022 | 0 | $0 | 5,000 | $1,300 | 0 | $0 |
| 2019 | 15,000 | $2,225 | 0 | $0 | 0 | $0 |
| 2015 | 2,275,093 | $3,292,508 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2023-06 | 130,000 | $5,200 | 0 | $0 | 0 | $0 |
| 2023-01 | 60,000 | $8,400 | 0 | $0 | 0 | $0 |
| 2022-07 | 0 | $0 | 5,000 | $1,300 | 0 | $0 |
| 2019-12 | 5,000 | $825 | 0 | $0 | 0 | $0 |
| 2019-10 | 10,000 | $1,400 | 0 | $0 | 0 | $0 |
| 2015-10 | 1,500 | $300 | 0 | $0 | 0 | $0 |
| 2015-09 | 2,263,593 | $3,282,208 | 0 | $0 | 0 | $0 |
| 2015-04 | 10,000 | $10,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-06-01 | Holden Lowell Thomas (CFO) | Buy | 130,000 | .04 | 5,200 |
| 2023-01-01 | Holden Lowell Thomas (CFO) | Buy | 40,000 | .14 | 5,600 |
| 2022-07-01 | Holden Lowell Thomas (CFO) | Sale | 5,000 | .26 | 1,300 |
| 2019-12-01 | Holden Lowell Thomas (CFO) | Buy | 5,000 | .17 | 825 |
| 2019-10-01 | Holden Lowell Thomas (CFO) | Buy | 10,000 | .14 | 1,400 |
| 2015-10-01 | Carrick Sean (Principal Executive Officer) | Buy | 1,500 | .20 | 300 |
| 2015-09-01 | Carrick Sean (Principal Executive Officer) | Buy | 1,028,901 | 1.45 | 1,491,906 |
| 2015-09-01 | Price Brandon (Senior VP Business Development) | Buy | 617,346 | 1.45 | 895,151 |
| 2015-09-01 | Holden Lowell Thomas (CFO) | Buy | 617,346 | 1.45 | 895,151 |
| 2015-04-01 | Karas Douglas John | Buy | 10,000 | 1.00 | 10,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of NBIO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Nascent Biotech Inc. (symbol NBIO, CIK number 1622057) see the Securities and Exchange Commission (SEC) website.